Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.

Stelloo, Ellen, Bosse, Tjalling, Nout, Remi A, MacKay, Helen J, Church, David N, Nijman, Hans W, Leary, Alexandra, Edmondson, Richard J +7 more·2015·Modern Pathology
DOI 10.1038/modpathol.2015.43

Cited by (491)

Items 401–491 of 491

  1. Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial Carcinoma
    Antonio Raffone, Antonio Travaglino, Diego Raimondo, Paolo Casadio, Renato Seracchioli, Gian Franco Zannoni, Antonio Mollo · 2022 · Journal of Personalized Medicine
  2. Cervical stromal invasion and molecular characterization in stage II-IV endometrial cancers
    Luigi Antonio De Vitis, Fiorella E. Reyes-Baez, Gabriella Schivardi, Maryam Shahi, Angela J. Fought, Michaela E. McGree, Ilaria Capasso, Leah O. Grcevich, Ilaria Betella, Mariacristina Ghioni et al. · 2025 · Gynecologic Oncology
  3. Hypermutated Colorectal Cancer and Neoantigen Load
    Mark A. Glaire, David N. Church · 2017 · Springer eBooks
  4. Screening tests for endometrial cancer in the general population
    Kelechi Njoku, Helena O’Flynn, Eleanor R Jones, Neal C. Ramchander, Helen White, Richard Macey, Emma Jayne Crosbie · 2021 · Cochrane Database of Systematic Reviews
  5. Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
    Chao Gao, Guangxu Jin, M. Elizabeth Forbes, Lingegowda Selanere Mangala, Yingmei Wang, Cristian Rodriguez‐Aguayo, Paola Amero, Emine Bayraktar, Ye Yan, Gabriel Lopez‐Berestein et al. · 2021 · Cancers
  6. Proceedings of the Expert Council “Treatment of inoperable endometrial cancer in Russia: issues that have not yet been addressed”
    Article Editorial · 2021 · Tumors of female reproductive system
  7. Molecular classification in endometrial cancer — are we ready?
    Agnieszka Rychlik, Mariusz Bidziński · 2023 · Ginekologia Polska
  8. Deep Learning-Based Screening for POLE mutations on Histopathology Slides in Endometrial Cancer
    Nikki van den Berg, Lydia A. Schoenpflug, Nanda Horeweg, Sarah Volinsky-Fremond, Jurriaan Barkey Wolf, Sonali Andani, Maxime W. Lafarge, Gitte Ørtoft, Jan J. Jobsen, Rubina R. Razack et al. · 2026 · medRxiv
  9. Endometrioid Carcinoma of the Ovary
    Laure De Cock, Gerlinde Avérous, Philippe Barthélémy, Jean‐Emmanuel Kurtz · 2016 · Springer eBooks
  10. The Molecular Pathology of Serous Endometrial Cancer
    Mary Ellen Urick, Meghan L. Rudd, Daphne W. Bell · 2017 · Molecular pathology library
  11. Prognostic roles of L1-cell adhesion molecule up-regulation in association with p53 overexpression and E-cadherin down-regulation in endometrial carcinoma patients
    Ola A. Megahed, Ola Abdelraouf Harb, Basant Sh El Shafaay, Ahmed Embaby · 2017 · Egyptian Journal of Pathology
  12. Controversies in Pathology and Advances in Molecular Diagnostics
    Sara Imboden, Denis Nastic, Joseph W. Carlson · 2019 · Springer eBooks
  13. Estudo prospectivo randomizado para avaliação dos desfechos peri-operatórios e custos em cirurgias laparoscópicas e robóticas para o estadiamento completo do carcinoma de endométrio
    Alexandre Silva e Silva · 2020
  14. Current trends in identifying biomarkers in endometrial cancer
    Brinderjeet Kaur · 2020 · The Gazette of Medical Sciences
  15. Molecular classification of endometrial cancers: The way forward
    Indranil Chakrabarti · 2020 · IP Archives of Cytology and Histopathology Research
  16. Retroactive assessment for DNA mismatch repair deficiency in women with a history of endometrial cancer
    Y. Chen, Sushmita Gordhandas, Kelsey Musselman, Zhen Zhou, Brandon Paul Maddy, Ryan Matthew Kahn, Nora M. Badiner, Lora H. Ellenson, Kevin Holcomb, Eloise Chapman‐Davis et al. · 2021 · Medical Research Archives
  17. Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts.
    Vladmir Cláudio Cordeiro-de-Lima, Luiz Henrique Araujo, Bernardo Garicochea, Vanderson Rocha, Max S. Mano, William Nassib William, Aline Lauda Freitas Chaves, Gustavo dos Santos Fernandes, Angélica Nogueira‐Rodrigues, Denis L. Fontes Jardim et al. · 2021 · Brazilian Journal of Oncology
  18. Molekulare Klassifikation beim Endometriumkarzinom
    Peter Bronsert, Konrad Kurowski, Martin Werner, C. Unger, Sylvia Timme · 2023 · Die Gynäkologie
  19. The cancer genome atlas - TCGA molecular classification
    Rahul D Modi · 2023 · Current Medicine Research and Practice
  20. Exploring the Diagnostic Potential of IHC and Next-Generation Sequencing Approaches for Endometrial Carcinoma Detection and Classification
    Azhin Saber Ali, Lana Sardar Alalem · 2023 · Journal of Clinical Medicine Current Research
  21. Genomic instability as a predictive biomarker for the application of DNA-damaging therapies in gynecological cancer patients
    Raquel López Reig · 2023
  22. Special Considerations in Classification and Workup of Endometrial Carcinomas
    Douglas A. Rottmann, Stephanie L. Skala · 2023 · Archives of Pathology & Laboratory Medicine
  23. The Shifting Landscape of p53abn Endometrial Cancers: A Review of the Prognostic and Predictive Impact and Current Therapeutic Directions
    Angelo Anater · 2023 · Journal of Medical and Radiation Oncology
  24. Prävention des Endometriumkarzinoms bei Lynch-Syndrom
    Kerstin Rhiem, Beyhan Ataseven, Nina Pauly, Nadine Kütting, Jacob Nattermann, Robert Hüneburg, Rita K. Schmutzler · 2023 · Die Gynäkologie
  25. Next-generation sequencing and immunohistochemistry approaches for microsatellite instability detection in endometrial cancer
    Azhin Saber Ali, Lana Sardar Alalem · 2023 · Cellular and Molecular Biology
  26. Additional file 4 of Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
    Yuan Li, Jiaqi Li, Ensong Guo, Jia Ming Huang, Guangguang Fang, Shaohua Chen, Bin Yang, Yu Fu, Fuxia Li, Zizhuo Wang et al. · 2020 · Figshare
  27. Additional file 1 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  28. Additional file 2 of Genomic profile of Chinese patients with endometrial carcinoma
    Li, Jin, Xiaoqi Li, Chenlian Quan, Xiaoqiu Li, Chong Wan, Xiaohua Wu · 2023 · Figshare
  29. Additional file 3 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  30. Additional file 2 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  31. Additional file 5 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  32. Additional file 4 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  33. Additional file 6 of Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
    Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long · 2021 · Figshare
  34. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer
    Asmerom Tesfamariam Sengal, Pamela M. Pollock · 2024 · Methods in molecular biology
  35. Applying Molecular Classification to Seven Endometrial Cancer Cell Lines – a Context for in Vitro Modeling of Radiation, Chemoradiation, Adjuvant Chemotherapy, and Beyond
    Alexander C. Cohen, Lulu Sun, Sarah Govert, Carolyn Kay McCourt, Stephanie T. Markovina · 2024 · SSRN Electronic Journal
  36. New lines of research in endometrial cancer
    M.ª Pilar Barretina Ginesta, Anna Carbó, Jaime Paz Molina · 2024 · Revisiones en cáncer
  37. Progress in the Study of Prognostic Factors and Risk Stratification in Early-Stage Endometrial Cancer: From Clinical Pathology to Molecular Integration
    鑫华 叶 · 2025 · Advances in Clinical Medicine
  38. Clinicopathological features of pathogenic, non-pathogenic, and unknown significance (NP/US) POLE mutations in endometrial carcinomas: A study based on actual world
    Yingying Fan, Dongni Liang, Juan Zou, Wei Kuang, Lingling Tong, Cheng Wang, Tianmin Liu, Wei Ting Wang, Min Feng · 2025 · Research Square
  39. Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19
    John McGrane, Leonie Eastlake, Dennis Hadjiyiannakis, S. Lalondrelle, Rebecca L. Bowen, Sally Trent, Mariam Obeid, E. Hudson, R. Agarwal, S. Gandhi et al. · 2025 · Clinical Oncology
  40. The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation
    Elif Akşahin, Fuat Demirkıran, Tugan Beşe, Sait Şükrü Çebi, Abdullah Serdar Açıkgöz, Başak Özge Kayan, Yeliz Aykanat, İsmail Yılmaz, Ayse Namal, Şennur İlvan et al. · 2025 · Journal of Gynecologic Oncology
  41. Integrated neoantigen and immune cell profiling of POLε-mutant colorectal tumors reveals distinct immune sub-types
    Nagesh Srikakulam, Vineeth Sukrithan, Wayne O. Miles · 2025 · Research Square
  42. Cardiac metastasis in endometrial carcinoma: A rare case report
    Liyuan Zhang, Zhilong Chen, Lu Wang, Yilin Guo, Hu Zhao · 2025 · Medicine
  43. Additional file 2 of Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
    Li, Yuan, Li, Jiaqi, Ensong Guo, Huang, Jia, Fang, Guangguang, Chen, Shaohua, Yang, Bin, Fu, Yu, Li, Fuxia, Wang, Zizhuo et al. · 2020 · Figshare
  44. Additional file 2 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  45. Additional file 1 of Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer
    Khalid Akkour, Alanazi, Ibrahim O, Alfadda, Assim A, Afshan Masood, H Alhalal, Salini Scaria Joy, Ali Bassi, Alshehri, Eman, Moudi A. Alwehaibi, Maria Arafah et al. · 2024 · Figshare
  46. Additional file 2 of Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics
    Liwei, Li, He, Li, Yibo, Dai, Luyang, Zhao, Zhihui, Shen, Nan, Kang, Danhua, Shen, Wang Junzhu, Wang Zhiqi, Jianliu, Wang · 2024 · Figshare
  47. Additional file 4 of Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
    Yu, Changmin, Xinhui Yuan, Yao, Qianlan, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Zhu, Xiaoli, Ren, Yulan · 2024 · Figshare
  48. Additional file 3 of Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
    Yu, Changmin, Xinhui Yuan, Yao, Qianlan, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Zhu, Xiaoli, Ren, Yulan · 2024 · Figshare
  49. Additional file 3 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  50. Additional file 3 of Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics
    Liwei, Li, He, Li, Yibo, Dai, Luyang, Zhao, Zhihui, Shen, Nan, Kang, Danhua, Shen, Wang Junzhu, Wang Zhiqi, Jianliu, Wang · 2024 · Figshare
  51. Additional file 1 of Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
    Yu, Changmin, Xinhui Yuan, Yao, Qianlan, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Zhu, Xiaoli, Ren, Yulan · 2024 · Figshare
  52. Additional file 2 of Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
    Yu, Changmin, Xinhui Yuan, Yao, Qianlan, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Zhu, Xiaoli, Ren, Yulan · 2024 · Figshare
  53. Additional file 1 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  54. Additional file 3 of Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
    Li, Yuan, Li, Jiaqi, Ensong Guo, Huang, Jia, Fang, Guangguang, Chen, Shaohua, Yang, Bin, Fu, Yu, Li, Fuxia, Wang, Zizhuo et al. · 2020 · Figshare
  55. Additional file 1 of Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
    Li, Yuan, Li, Jiaqi, Ensong Guo, Huang, Jia, Fang, Guangguang, Chen, Shaohua, Yang, Bin, Fu, Yu, Li, Fuxia, Wang, Zizhuo et al. · 2020 · Figshare
  56. Additional file 6 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  57. Additional file 4 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  58. Additional file 1 of Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics
    Liwei, Li, He, Li, Yibo, Dai, Luyang, Zhao, Zhihui, Shen, Nan, Kang, Danhua, Shen, Wang Junzhu, Wang Zhiqi, Jianliu, Wang · 2023 · Figshare
  59. Additional file 5 of The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
    Wu, Qing, Nianhai Zhang, Xianhe Xie · 2022 · Figshare
  60. Additional file 1 of Genomic profile of Chinese patients with endometrial carcinoma
    Li, Jin, Li, Xiaoqi, Quan, Chenlian, Li, Xiaoqiu, Chong Wan, Xiaohua Wu · 2023 · Figshare
  61. FIGO2023 Staging System and Molecular Classification for Endometrial Cancer
    Hiroyuki Yamazaki, Hiroshi Asano · 2025 · Comprehensive gynecology and obstetrics
  62. Clonal Progression of a DNA Polymerase Epsilon–Mutant Endometrial Cancer With Immune Evasion Characteristics and Metastasis
    Ruirui Fan, Jie Gao · 2026 · Laboratory Investigation
  63. Comparing multi-b-value diffusion models and ROI delineation strategies for prediction of p53 abnormality and microsatellite instability in endometrial cancer
    yi li, Xuemei Wang, Kaiming Xue, Yunhai Mao, Wenchao Wang, Xiaoming Liu, Wei Wang, Mengchao Zhang · 2026 · BMC Medical Imaging
  64. Treatment Option for Deficient Mismatch Repair (dMMR) and Proficient Mismatch Repair (pMMR) in Endometrial Cancer
    I Gde Sastra Winata, Jessica Nathalia, Prayascita Mahendrata · 2026 · Journal of South Asian Federation of Obstetrics and Gynaecology
  65. Prognostic role of estrogen receptor, L1 cell adhesion molecule, and tumor grade in patients with endometrial carcinoma of no specific molecular profile
    Wanja Kildal, Manohar Pradhan, Gunnar Balle Kristensen, Ljiljana Vlatkovic, Kari Anne R. Tobin, Tarjei S. Hveem, Kristina Yvonne Lindemann, Hanne Arenberg Askautrud, Andreas Kleppe · 2026 · International Journal of Gynecological Cancer
  66. Recurrence-Related Factors in Early Stage Endometrial Cancer
    Necim Yalçın, Aysun Alcı, Mustafa Gökkaya, Tayfun Toptaş, Işın Üreyen · 2026 · Sakarya Medical Journal
  67. Étude des paralogues ARHGAP35/p190A et ARHGAP5/p190B et de leur impact dans le cancer de l’endomètre
    M. Pinault · 2022
  68. Apport de l'ADN circulant tumoral dans les cancers digestifs
    Camille Evrard · 2022 · theses.fr (ABES)
  69. FEMALE REPRODUCTIVE TRACT
    Donald Barceloux MD, FAACT, FACMT, FACEP, Robert B. Palmer PhD, DABAT, FAACT · 2026 · Medical Toxicology
  70. Molecular Classification as a Predictor of Nodal Involvement and Survival Outcomes in Presumed Early-Stage Endometrial Cancer
    Irene Pellicer, Blanca Diaz, María Alonso-Espías, Ignacio Zapardiel, Myriam Gracia · 2026 · Cancers
  71. Context-Dependent Alterations of E-Cadherin, β-Catenin, and Vimentin in Endometrial Ciliated Epithelial Change: An Exploratory Immunohistochemical Study
    Teona Turashvili, George Tevdorashvili, George Burkadze · 2026 · Diagnostics
  72. No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma
    Famke C. Wakkerman, Cathalijne Post, Gitte Ørtoft, Estrid Vilma Solyom Høgdall, Jan J. Jobsen, Rubina R. Razack, Cor Doede de Kroon, Remi A. Nout, Dorine S.J. Tseng, Nienke Kuijsters et al. · 2026 · European Journal of Cancer
  73. Updates on molecular classification and treatment in endometrial cancer
    Kensuke Sakai, Takuma Yoshimura, Wataru Yamagami · 2026 · Japanese Journal of Radiology
  74. p53 Overexpression in an Ovarian Adult Granulosa Cell Tumor Without Anaplastic Morphology: A Marker of Aggressive Behavior?
    Reiji Muto, Nao Yamamoto, Mika Takaki, Takahiro Kusaba, Haruto Nishida, Hiroaki Motokawa, Chiaki Asao, Yoshiki Mikami · 2026 · International Journal of Gynecological Pathology
  75. Endometrial cancer
    Megan A. Clarke, Akemi T. Wijayabahu · 2026 · Elsevier eBooks
  76. The current molecular landscape of endometrial and ovarian carcinomas: insights and practical updates
    Swati Bhardwaj, Natalie Banet · 2026 · Seminars in Diagnostic Pathology
  77. Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer
    Yesul Jeong, Sungman Hong, Sangjeong Ahn, Sung Hak Lee · 2026 · International Journal of Molecular Sciences
  78. Molecular classification of endometrial carcinoma: clinical utility of an NGS panel with targeted detection of 116 cancer-related genes
    Lingfeng Chen, Zhijie You, Xunbin Yu, Yijuan Wu, X Y Chen, Jie Lin · 2026 · Pathology & Oncology Research
  79. Molecular Classification of Endometrial Cancer
    Marco Antonio Terán Porcayo · 2026 · Springer eBooks
  80. A história contemporânea do carcinoma do endométrio
    Alexandre Silva e Silva, Filomena Marino Carvalho, Jesus Paula Carvalho · 2020 · Femina
  81. Assessing Foundation Models for Computational Pathology in Endometrial Cancer
    Nikki van den Berg, Sarah Volinsky-Fremond, Jurriaan Barkey Wolf, Lydia A. Schoenpflug, Sonali Andani, Gitte Ørtoft, Jan J. Jobsen, Ludy C.H.W. Lutgens, Melanie E. Powell, Linda Mileshkin et al. · 2026 · Modern Pathology
  82. Molecular characterization of NSMP endometrial cancer and its relevance for treatment
    Tarik Silk, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos · 2026 · Gynecologic Oncology
  83. Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic Strategies—A Systematic Review
    Gulinur Chinaliyeva, Azat Chinaliyev, Амирбекова Жанна Туймебаевна, Amankeldi A. Salybekov, Aida Shakirova, Didar Khassenov, Zhandos K. Burkitbayev, Nino Dznelashvili · 2026 · Diagnostics
  84. Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer
    Miłosz Pietrus, Marcin Waligóra, Maciej Władysław Socha, Klaudia Skrzypek, Monika Kabzińska-Turek, Rene Laky, Iwona Gawron · 2026 · Frontiers in Oncology
  85. Refining the TCGA Framework: The Pivotal Role of Targeted Next-Generation Sequencing in Resolving Diagnostic Ambiguities in Endometrial Cancer—Systematic Review
    Natalia Gierulska, Julia Orzelska, Katarzyna Lachowska, Amelia Trzcińska, Karolina Mazur, Natalia Picheta, Julia Piekarz, Patrycja Wójcikiewicz, Iwona Puzio, Ewa Tomaszewska et al. · 2026 · International Journal of Molecular Sciences
  86. Endometrial cancer molecular classification: research advances and clinical application
    Ya Liu, Yueying Li, Liping Zhang · 2026 · Frontiers in Oncology
  87. Malignant Tumors of the Uterine Corpus in the Era of Molecular Oncology: How Mutations Change Approaches to Adjuvant Treatment
    Лушникова Полина Александровна, Жанна Александровна Старцева, Алексей Александрович Поляков, A. V. Taletskiy, V. V. Velikaya, О. В. Грибова · 2026 · Creative Surgery and Oncology
  88. Integrated Molecular Classification of Endometrial Cancer: Impact on Diagnosis, Prognosis, and Clinical Management—A Systematic Review
    Silvio Antonio Galeano Reyes, Eugenia Fraile‐Bethencourt, Serena Lacerenza, Carmen Camacho García, E Rodríguez, Pablo Bueno Ortiz, Víctor Macarrón, Ivan Domazetovski, Miguel Andújar Sánchez · 2026 · Cancers
  89. Beyond Molecular Classification: The Incremental Value of Prognostic Biomarkers in Endometrial Cancer
    Vlad Gabriel Tîrnovanu, Iustina Petra Solomon Condriuc, Raluca Anamaria Mogoş, Daniela Roxana Matasariu, Alexandru George Filipescu, Mihaela Burac, Mihaela Camelia Tîrnovanu, Demetra Gabriela Socolov, Alexandru Cărăuleanu · 2026 · Journal of Clinical Medicine
  90. Prognostic Significance of Amino Acid Transporters in Endometrial Cancer
    Mikołaj Piotr Zaborowski, Łukasz Ciecierski, Piotr Tyburski, Magdalena Nadolna, Marta Brygida Szczygieł, Jędrzej Sikora, Mateusz Szot, Stefan Malewski, Marcin Iwanicki, Kinga Piątek-Bajan et al. · 2026 · Cancers
  91. Molecular Classification and Prognostic Factors in Endometrial Cancer: A Multicenter Retrospective Cohort Study
    Kai‐Hung Wang, Chun-Shuo Hsu, Kuo-Hu Chen, Chiu-Hsuan Cheng, Dah‐Ching Ding · 2026 · Current Issues in Molecular Biology